PRELUDE THERAPEUTICS INC
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | $4.8M | $21.9M | $18.9M |
| Sep 2020 | $11.4M | $239.7M | $234.8M |
| Dec 2020 | $11.4M | $223.6M | $218.3M |
| Mar 2021 | $13.3M | $369.8M | $363.0M |
| Jun 2021 | $15.2M | $349.6M | $343.1M |
| Sep 2021 | $20.0M | $331.2M | $61.4M |
| Dec 2021 | $19.2M | $305.1M | $31.8M |
| Mar 2022 | $18.9M | $280.7M | $51.6M |
| Jun 2022 | $18.2M | $259.1M | $50.7M |
| Sep 2022 | $24.9M | $242.3M | $52.0M |
| Dec 2022 | $25.1M | $220.5M | $30.6M |
| Mar 2023 | $23.0M | $198.3M | $18.2M |
| Jun 2023 | $18.6M | $280.6M | $26.4M |
| Sep 2023 | $20.3M | $258.5M | $15.9M |
| Dec 2023 | $40.6M | $277.7M | $25.3M |
| Mar 2024 | $36.4M | $247.1M | $24.7M |
| Jun 2024 | $42.0M | $224.3M | $27.8M |
| Sep 2024 | $40.8M | $197.2M | $11.1M |
| Dec 2024 | $44.1M | $175.5M | $12.5M |
| Mar 2025 | $38.1M | $141.3M | $40.3M |
| Jun 2025 | $39.1M | $114.9M | $25.8M |
| Sep 2025 | $36.2M | $94.8M | $47.5M |
| Dec 2025 | $72.7M | $141.3M | $35.3M |
| Mar 2026 | $59.5M | $119.6M | $21.8M |
| Jun 2026 | $55.6M | $189.4M | $26.3M |